PNPLA3 and fatty liver disease: Furthermore, although the studies in PNPLA3 knockout or transgenic mice that overexpressed PNPLA3 led to conflicting results [25,26,27], the loss-of-function I148M variant has been shown to promote hepatic steatosis [28,29].